European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 9, 2014, Pages 1623-1630

  Tortorano, A M ^a   Prigitano, A ^a   Esposto, M C ^a   Arsic Arsenijevic, V ^b   Kolarovic, J ^c   Ivanovic, D ^d   Paripovic, L ^e   Klingspor, L ^f   Nordoy I ^g   Hamal, P ^h   Arikan Akdagli, S ⁱ   Ossi, C ^j   Grancini, A ^k   Cavanna, C ^l   Lo Cascio, G ^m   Scarparo, C ⁿ   Candoni, A ⁿ   Caira, M ^o   Drogari Apiranthitou, M ^p  

^a UNIVERSITY OF MILAN   (Italy)

^b Institut Za Mikrobiologiju I Imunologiju Univerziteta U Beogradu   (Serbia)

^c Institute for Child and Youth Health Care of Vojvodina   (Serbia)

^d Institute of Public Health of Serbia   (Serbia)

^e INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

^h PALACKÝ UNIVERSITY   (Czech Republic)

ⁱ HACETTEPE UNIVERSITY   (Turkey)

^j Diagnostica e Ricerca San Raffaele   (Italy)

^k FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^l FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^m UNIVERSITY HOSPITAL OF VERONA   (Italy)

ⁿ SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^o CATHOLIC UNIVERSITY   (Italy)

^p UNIVERSITY OF ATHENS   (Greece)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ELONGATION FACTOR 1ALPHA; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT; ELONGATION FACTOR 1; FUNGAL PROTEIN;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CHILD; EUROPE; FEMALE; FUNGAL GENE; FUNGAL STRAIN; FUNGUS ISOLATION; FUSARIOSIS; FUSARIUM; FUSARIUM FUJIKUROI; FUSARIUM MONILIFORME; FUSARIUM PROLIFERATUM; FUSARIUM SOLANI; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; PRIORITY JOURNAL; CLASSIFICATION; DNA SEQUENCE; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SURVIVAL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; EUROPE; FEMALE; FUNGAL PROTEINS; FUSARIOSIS; FUSARIUM; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PEPTIDE ELONGATION FACTOR 1; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84906058932     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2111-1     Document Type: Article

References (29)

1. Nucci M, Anaissie E (2007) Fusarium infections in immunocompromised patients. Clin Microbiol Rev 20:695-704. doi:10.1128/CMR.00014-07 (Pubitemid 47623773)
2. Campo M, Lewis RE, Kontoyiannis DP (2010) Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009. J Infect 60:331-337. doi:10.1016/j.jinf.2010.01.010
3. Guarro J (2013) Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment. Eur J Clin Microbiol Infect Dis 32:1491-1500. doi:10.1007/s10096-013-1924-7
4. O'Donnell K, Sutton DA, Rinaldi MG, Sarver BA, Balajee SA, Schroers HJ et al (2010) Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. J Clin Microbiol 48:3708- 3718. doi:10.1128/JCM.00989-10
5. Seifert KA, Aoki T, Baayen RP, Brayford D, Burgess LW, Chulze S et al (2003) The name Fusarium moniliforme should no longer be used. Mycol Res 107:643-644. doi:10.1017/S095375620323820X (Pubitemid 36946742)
6. Tortorano AM, Prigitano A, Dho G, Esposto MC, Gianni C, Grancini A et al (2008) Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy. Antimicrob Agents Chemother 52:2683-2685. doi:10.1128/AAC.00272-08 (Pubitemid 351915710)
7. Arikan S, Lozano-Chiu M, Paetznick V, Nangia S, Rex JH (1999) Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species. J Clin Microbiol 37:3946-3951
8. Paphitou NI, Ostrosky-Zeichner L, Paetznick VL, Rodriguez JR, Chen E, Rex JH (2002) In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results. Antimicrob Agents Chemother 46:3298-3300
9. Azor M, Gené J, Cano J, Guarro J (2007) Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex. Antimicrob Agents Chemother 51:1500-1503. doi:10.1128/AAC.01618-06 (Pubitemid 46586837)
10. Iqbal NJ, Boey A, Park BJ, Brandt ME (2008) Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods. Diagn Microbiol Infect Dis 62:348-350. doi:10.1016/j.diagmicrobio.2008. 07.003
11. Alastruey-Izquierdo A, Cuenca-Estrella M, Monzón A, Mellado E, Rodríguez-Tudela JL (2008) Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. J Antimicrob Chemother 61:805 -809. doi: 10.1093/jac/dkn022
12. Lortholary O, Obenga G, Biswas P, Caillot D, Chachaty E, Bienvenu AL et al (2010) International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole. Antimicrob Agents Chemother 54:4446-4450
13. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813-1821. doi:10.1086/588660
14. Geiser DM, del Mar Jiménez-Gasco M, Kang S, Makalowska I, Veeraraghavan N, Ward TJ et al (2004) FUSARIUM-ID v. 1.0: a DNA sequence database for identifying Fusarium. Eur J Plant Pathol 110:473-479 (Pubitemid 39001449)
15. O'Donnell K, Kistler HC, Cigelnik E, Ploetz RC (1998) Multiple evolutionary origins of the fungus causing Panama disease of banana: concordant evidence from nuclear and mitochondrial gene genealogies. Proc Natl Acad Sci U S A 95:2044-2049 (Pubitemid 28145891)
16. O'Donnell K, Sutton DA, Fothergill A, McCarthy D, Rinaldi MG, Brandt ME et al (2008) Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex. J Clin Microbiol 46:2477-2490. doi:10.1128/JCM.02371-07
17. Rodriguez-Tudela JL, Arendrup MC, Arikan S, Barchiesi F, Bille J, Chryssanthou E, et al (2008) EUCAST DEFINITIVE DOCUMENT E.DEF 9.1:Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds. EUCAST E.DEF 9.1.:1-13
18. Guarner J, Brandt ME (2011) Histopathologic diagnosis of fungal infections in the 21st century. Clin Microbiol Rev 24:247-280. doi: 10.1128/CMR.00053-10
19. Thomas PA, Jesudasan CA, Geraldine P, Kaliamurthy J (2011) Adventitious sporulation in Fusarium keratitis. Graefes Arch Clin Exp Ophthalmol 249:1429-1431
20. Nucci M, Anaissie E, Queiroz-Telles F, Martins CA, Trabasso P, Solza C et al (2003) Outcome predictor of 84 patients with hematologic malignancies and Fusarium infection. Cancer 98:315-319. doi: 10.1002/cncr.11510 (Pubitemid 36828456)
21. Nucci M, Marr KA, Queiroz-Telles F, Martins CA, Trabasso P, Costa S et al (2004) Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis 38:1237-1242. doi:10.1086/383319 (Pubitemid 38608564)
22. Geiser DM, Aoki T, Bacon CW, Baker SE, Bhattacharyya MK, Brandt ME et al (2013) One Fungus, one name: defining the genus Fusarium in a scientifically robust way that preserves longstanding use. Phytopathology 103:400-408. doi:10.1094/PHYTO-07-12-0150-LE
23. Lionakis MS, Kontoyiannis DP (2004) Fusarium infections in critically ill patients. Semin Respir Crit Care Med 25:159-169 (Pubitemid 38544248)
24. Nucci M, Anaissie EJ (2009) Hyalohyphomycosis. In: Anaissie EJ, McGinnis MR, Pfaller MA (eds) Clinical mycology, 2nd edn. Churchill Livingstone, St. Louis, MO, USA, pp 309-327
25. Debourgogne A, de Hoog S, Lozniewski A, Machouart M (2012) Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSIM38-A2 microdilution methodology. Eur J Clin Microbiol Infect Dis 31:615-618. doi:10.1007/s10096-011-1323-x
26. Tortorano AM, Richardson M, Roilides E, van Diepeningen A, Caira M, Munoz P et al (2014) ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect 20(Suppl 3):27-46. doi:10.1111/1469-0691.12465
27. Nucci M, Marr KA, Vehreschild MJ, de Souza CA, Velasco E, Cappellano P et al (2013) Improvement in the outcome of invasive fusariosis in the last decade. Clin Microbiol Infect. doi:10.1111/1469-0691.12409
28. Raad II, Hachem RY, Herbrecht R, Graybill JR, Hare R, Corcoran G et al (2006) Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis 42:1398-1403
29. de Hoog GS, Haase G, Chaturvedi V, Walsh TJ, Meyer W, Lackner M (2013) Taxonomy of medically important fungi in the molecular era. Lancet Infect Dis 13:385-386. doi:10.1016/S1473-3099(13)70058-6